Who owns Editas Medicine, Inc.?
Institutional ownership of EDIT from SEC Form 13F filings across 157 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
157
13F holders
$197.0M
value, 2026 filers
40.6%
of shares outstanding (62.3M sh)
20
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of EDIT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TCG Crossover Management, LLCNEW | 11.1M | $36.0M | 0.9% | 7.2% | new |
| 2 | BlackRock, Inc. | 10.6M | $34.3M | 0.0% | 6.9% | +14.3% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 6.1M | $19.9M | 0.0% | 4% | -27.0% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 3.6M | $11.7M | 0.0% | 2.3% | +14.3% |
| 5 | Woodline Partners LPNEW | 3.6M | $11.5M | 0.0% | 2.3% | new |
| 6 | GOLDMAN SACHS GROUP INC | 2.6M | $8.5M | 0.0% | 1.7% | +368.0% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 2.6M | $8.3M | 0.0% | 1.7% | +11.1% |
| 8 | MARSHALL WACE, LLP | 2.0M | $6.6M | 0.0% | 1.3% | +868.7% |
| 9 | D. E. Shaw & Co., Inc. | 1.9M | $6.2M | 0.0% | 1.2% | -2.2% |
| 10 | JPMORGAN CHASE & CO | 1.9M | $6.0M | 0.0% | 1.2% | -4.4% |
| 11 | TWO SIGMA INVESTMENTS, LP | 1.3M | $4.3M | 0.0% | 0.9% | -13.9% |
| 12 | RAYMOND JAMES FINANCIAL INC | 1.3M | $4.3M | 0.0% | 0.9% | +1.9% |
| 13 | ACADIAN ASSET MANAGEMENT LLC | 1.0M | $3,364 | 0.0% | 0.7% | -28.7% |
| 14 | MACKENZIE FINANCIAL CORP | 878,042 | $2.8M | 0.0% | 0.6% | +20.3% |
| 15 | Sixth Street Partners Management Company, L.P.NEW | 868,032 | $2.8M | 0.5% | 0.6% | new |
| 16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 868,032 | $2.8M | 0.0% | 0.6% | +0.8% |
| 17 | NORTHERN TRUST CORP | 819,693 | $2.7M | 0.0% | 0.5% | +10.4% |
| 18 | UBS Group AG | 750,763 | $2.4M | 0.0% | 0.5% | +90.7% |
| 19 | VANGUARD FIDUCIARY TRUST CO | 742,950 | $2.4M | 0.0% | 0.5% | +21.0% |
| 20 | Nuveen, LLC | 521,213 | $1.7M | 0.0% | 0.3% | -73.6% |
| 21 | MILLENNIUM MANAGEMENT LLCNEW | 498,997 | $1.6M | 0.0% | 0.3% | new |
| 22 | PEAK6 LLCNEW | 415,441 | $1.3M | 0.0% | 0.3% | new |
| 23 | MORGAN STANLEY | 342,165 | $1.1M | 0.0% | 0.2% | -16.8% |
| 24 | Cambridge Investment Research Advisors, Inc. | 323,756 | $1,048 | 0.0% | 0.2% | +81.4% |
| 25 | WELLINGTON MANAGEMENT GROUP LLPNEW | 309,395 | $1.0M | 0.0% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.